Neoplasms Malignant Completed Phase 1 Trials for Leucovorin (DB00650)

Also known as: Malignant Tumor / Neoplasm Malignant / Malignant Tumors / Malignant Neoplasm / Malignant Neoplasms / Neoplasm, Malignant / Neoplasms, Malignant / Disorder: Primary malignant neoplasm (disorder) / Malignant tumor (disorder) / Malignant neoplasms (& carcinoma) / Malignant neoplasm NOS (& sarcoma NOS) / Malignant neoplasm NOS / (Neoplasms) or (cancers) / Cancer NOS / Cancer / Malignant neoplasm of unspecified site NOS (disorder) / Ca - unspecified site NOS (disorder) / Ca - unspecified site NOS / (Ca unspecified site) or (secondary - unknown site) / Malignant tumour / [X]Malignant neoplasm without specification of site (disorder) / Malignant neoplasm of unspecified site (disorder) / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0047288 (Neoplasms Malignant)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01930552A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesTreatment